The mRNA expression profile microarray data were obtained from the GEO dataset: GSE7158 series included 12 OP (low bone density) samples and 14 NC (high bone density) samples; GSE56814 series included 31 pre-treatment samples (15 OP and 16 NC) and 43 prognostic samples, and GSE56815 series included 40 pre-treatment samples (20 OP and 20 NC) and 40 post-treatment samples. For GSE56814 and GSE56815, sample data before treatment were used for difference analysis. As this study involves only a bioinformatics analysis of the GEO data set, no ethical approval was required. The inclusion criteria included age >18 years, osteoporosis fractures grades 1–4 according to OF classification, pathological fractures: osteoporotic fractures, fracture of at least 1 vertebral body, fractures of thoracic or lumbar vertebral body. The exclusion criteria included pathological neoplastic fractures, osteoporosis fractures (OF) grade 5 according to OF classification and AO type B and C fractures.
Free full text: Click here